Our results showing an increase in the alpha subunit of CD8 (CD8A) being significantly associated with longer PFS in the TT patient group can be an indication of the importance of tumor-directed immunity in TT (Supplementary Table S10). The gene discussed is CD8A; the disease is neoplasm.